CNSP MEXC RealStocks
Own real CNSP shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 23:09:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
CNS Pharmaceuticals, Inc. (CNSP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.70, with a market capitalization of $5.63M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.90 to $10.54. This page covers its latest market performance, valuation, price trends and company information.
$5.63M | |
$3.75 | |
$3.91 | |
$3.70 | |
$3.62 | |
2.37K | |
9.82K | |
-- | |
$10.54 | |
$1.90 | |
-- | |
-- |
CNS Pharmaceuticals, Inc. (CNSP) is trading at $3.67 in after-hours trading as of 2026-11-12 21:11:00, down 0.81% ($0.03) from the regular-session close of $3.70.
After-hours trading shows how investors are pricing CNSP after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, CNS Pharmaceuticals, Inc. (CNSP) moved from $4.55 to $3.70, representing a decline of 18.79% ($0.86).
The stock traded between $3.62 and $4.70 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 6.56 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 20.8%
CNSP is currently trading at $3.70, placing it 20.8% of the way from its 52-week low of $1.90 to its 52-week high of $10.54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 8 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for CNS Pharmaceuticals, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of CNS Pharmaceuticals, Inc. (CNSP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CNSP, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between CNSP shares and USD.
CNSP Shares to USD
1.00 CNSP shares = 3.695 USD
Calculations are estimates based on the latest available price and are for reference only.